Redsense Medical AB (publ) annual report 2019
As of today, the Annual Report for Redsense Medical AB (publ.) For the 2019 financial year is available for download from Redsense Medical's website www.redsensemedical.com.
A printed version can be ordered from:
Redsense Medical AB
Gyllenhammars väg 26
302 92 Halmstad
For more information, please contact:
CEO Patrik Byhmer
Telephone: +4670-357 21 64
About Redsense Medical
Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimizing blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.
Redsense Medical is obliged to make the information contained herein public pursuant to the EU market abuse regulation. The information was submitted for publication through the agency of the contact person above at CET 08:30 on Monday, June 1, 2020